Stage II Non-Small Cell Lung Cancer

Also known as: Non-small Cell Lung Cancer Stage II / Nonsmall Cell Lung Cancer, Stage II / Lung Cancer Non-Small Cell Stage II / NSCLC Stage II / NSCLC, Stage II

DrugDrug NameDrug Description
DB11595AtezolizumabA monoclonal antibody used to treat advanced or metastatic urothelial carcinoma with disease progression during or up to 12 months after platinum-containing chemotherapy.
DB09037PembrolizumabA PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma.
DrugDrug NamePhaseStatusCount
DB00062Albumin human0Terminated1
DB00958Carboplatin0Terminated1
DB01229Paclitaxel0Terminated1
DB00112Bevacizumab1Terminated1
DB00958Carboplatin1Active Not Recruiting1
DB00958Carboplatin1Terminated1
DB01229Paclitaxel1Active Not Recruiting1
DB01229Paclitaxel1Terminated1
DB09037Pembrolizumab1Active Not Recruiting1
DB09037Pembrolizumab1Recruiting1
DB11714Durvalumab1 / 2Not Yet Recruiting1
DB09035Nivolumab1 / 2Active Not Recruiting1
DB11595Atezolizumab2Recruiting1
DB00958Carboplatin2Recruiting1
DB00958Carboplatin2Unknown Status1
DB00515Cisplatin2Completed1
DB00515Cisplatin2Unknown Status1
DB11714Durvalumab2Active Not Recruiting1
DB11714Durvalumab2Recruiting2
DB00530Erlotinib2Active Not Recruiting1
DB00441Gemcitabine2Completed1
DB00441Gemcitabine2Unknown Status1
DB14865Human interleukin-22Completed1
DB15483Modified vaccinia ankara2Completed1
DB06132Nivolumab2Completed1
DB09035Nivolumab2Completed2
DB09035Nivolumab2Recruiting1
DB09330Osimertinib2Active Not Recruiting1
DB01229Paclitaxel2Recruiting1
DB09037Pembrolizumab2Recruiting1
DB09037Pembrolizumab2Unknown Status1
DB00642Pemetrexed2Completed1
DB00642Pemetrexed2Unknown Status1
DB12257Platinum2Completed1
DB05578Ramucirumab2Recruiting1
DB14851Relatlimab2Recruiting1
DB06584TG40102Completed1
DB00112Bevacizumab2 / 3Not Yet Recruiting1
DB17451Serplulimab2 / 3Not Yet Recruiting1
DB05296Motexafin lutetiumNot AvailableTerminated1